Is prevaccination screening for hepatitis B among sexually active adolescents cost-effective?

E. M. Alderman; A. Shapiro; I. Spigland; M. Bashir; A. S. Fox

doi:10.1086/516346

Is prevaccination screening for hepatitis B among sexually active adolescents cost-effective?

E. M. Alderman, A. Shapiro, I. Spigland, M. Bashir, A. S. Fox

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1459-1460
Number of pages	2
Journal	Clinical Infectious Diseases
Volume	26
Issue number	6
DOIs	https://doi.org/10.1086/516346
State	Published - 1998

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1086/516346

Cite this

@article{91689728ff7c4a5190c9e9232ad733ad,

title = "Is prevaccination screening for hepatitis B among sexually active adolescents cost-effective?",

author = "Alderman, {E. M.} and A. Shapiro and I. Spigland and M. Bashir and Fox, {A. S.}",

note = "Funding Information: This work was presented in part at the 35th Annual Ambulatory Pediatrics Association Meeting held on 7–11 May 1995 in San Diego, California. Informed consent was obtained from the patients, and the study was approved by the Montefiore Medical Center Institutional Review Board. Financial Support: This work was supported in part by Abbott Laboratories, Abbott Park, Illinois. Reprints or correspondence: Dr. Amy S. Fox, Division of Virology, Mon-tefiore Medical Center, Moses 9, 111 East 210 Street, Bronx, New York 10467.",

year = "1998",

doi = "10.1086/516346",

language = "English (US)",

volume = "26",

pages = "1459--1460",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",